524564 GAYATRIBI

Gayatri BioOrganics Share Price

 

 

Start SIP in GAYATRIBI

Start SIP

Performance

  • Low
  • ₹14
  • High
  • ₹15
  • 52 Week Low
  • ₹6
  • 52 Week High
  • ₹20
  • Open Price₹14
  • Previous Close₹14
  • Volume1,396
  • 50 DMA₹14.09
  • 100 DMA₹13.36
  • 200 DMA₹11.84

Investment Returns

  • Over 1 Month + 13.89%
  • Over 3 Month + 14.91%
  • Over 6 Month + 36.23%
  • Over 1 Year + 136.18%

Smart Investing Starts Here Start SIP with Gayatri BioOrganics for Steady Growth!

Invest Now

Gayatri BioOrganics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -128.3
  • PEG Ratio
  • 11.9
  • Market Cap Cr
  • 111
  • P/B Ratio
  • -3.1
  • Average True Range
  • 0.94
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.07
  • RSI
  • 49.16
  • MFI
  • 37.87

Gayatri BioOrganics Financials

Gayatri BioOrganics Technicals

EMA & SMA

Current Price
₹14.10
+ 0.1 (0.71%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹14.17
  • 50 Day
  • ₹14.09
  • 100 Day
  • ₹13.36
  • 200 Day
  • ₹11.84

Resistance and Support

14.2 Pivot Speed
  • R3 14.90
  • R2 14.70
  • R1 14.40
  • S1 13.90
  • S2 13.70
  • S3 13.40

Gayatri BioOrganics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-10 Quarterly Results
2025-11-13 Quarterly Results
2025-07-29 Quarterly Results
2025-05-28 Audited Results
2025-01-20 Quarterly Results

Gayatri BioOrganics F&O

Gayatri BioOrganics Shareholding Pattern

21.59%
0.65%
0.01%
52.91%
24.84%

Gayatri BioOrganics FAQs

Gayatri BioOrganics share price is ₹14 As on 21 February, 2026 | 07:06

The Market Cap of Gayatri BioOrganics is ₹111.1 Cr As on 21 February, 2026 | 07:06

The P/E ratio of Gayatri BioOrganics is -128.3 As on 21 February, 2026 | 07:06

The PB ratio of Gayatri BioOrganics is -3.1 As on 21 February, 2026 | 07:06

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23